Global Leukapheresis Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Leukapheresis Devices, Centrifugal Devices, Membrane Separators, and Leukapheresis Disposables

By Application;

Research Applications, and Therapeutic Applications

By End User;

Blood Component Providers & Blood Centers , Academic & Research Institutes , Pharmaceutical & Biotechnology Companies, and Hospitals & Transfusion Centers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn306812259 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global Leukapheresis Market (USD Million), 2021 - 2031

Leukapheresis Market was valued at USD 13,263.01 million in the year 2024. The size of this market is expected to increase to USD 22,878.20 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.1%.


Global Leukapheresis Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 8.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)8.1 %
Market Size (2024)USD 13,263.01 Million
Market Size (2031)USD 22,878.20 Million
Market ConcentrationMedium
Report Pages361
13,263.01
2024
22,878.20
2031

Major Players

  • Asahi Kasei Medical Co. Ltd
  • Fresenius Se & Co. KGaA
  • Haemonetics Corporation
  • Hemacare Corporation
  • Key Biologics LLC
  • Terumo BCT
  • ALLCells LLC
  • Stemexpress LLC
  • Stemcell Technologies Inc
  • Caltag Medsystems Limited
  • Zenbio Inc
  • Precision for Medicine Inc
  • PPA Research Group Inc
  • Bioivt
  • Macopharma SA

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Leukapheresis Market

Fragmented - Highly competitive market without dominant players


The Leukapheresis Market is steadily growing, primarily driven by the rising demand for procedures that enable the extraction and use of white blood cells in treatment and research. Leukapheresis has emerged as a vital component in managing conditions like leukemia and autoimmune disorders. Notably, therapeutic applications now represent over 50% of all procedures, underscoring their increasing relevance in clinical care.

Rising Influence of Cell-Based Immunotherapies
One of the key drivers of market growth is the growing reliance on CAR-T and other T-cell-based therapies, which require leukapheresis to collect immune cells for processing. More than 45% of ongoing research in cell-based treatments depends on these procedures, making leukapheresis a central process in the advancement of precision medicine.

Technological Innovation in Apheresis Equipment
The evolution of automated leukapheresis systems has significantly improved procedural efficiency and patient outcomes. Newer systems now offer real-time monitoring and enhanced yield capabilities, with about 40% of current devices featuring integrated control technologies that simplify operations and reduce procedural risks.

Accelerating Research and Development Activities
The surge in biomedical and immunotherapy research has elevated the demand for leukapheresis services across academic. Roughly 35% of current clinical trials in this domain utilize leukapheresis for the isolation of critical cell populations, making it a fundamental tool in advanced therapeutic development.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Leukapheresis Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Incidence of Blood Cancer
        2. Demand for Stem Cell Transplantation
        3. Technological Advancements in Leukapheresis
        4. Research in Immunotherapy and Cell-based Therapies
      2. Restraints
        1. Shortage of Skilled Healthcare Professionals
        2. Ethical and Regulatory Challenges
        3. Procedure Risks and Complications
      3. Opportunities
        1. Expansion in emerging healthcare markets
        2. Integration with personalized medicine approaches
        3. Development of portable leukapheresis systems
        4. Collaborations for novel therapeutic applications
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Leukapheresis Market, By Product, 2021 - 2031 (USD Million)
      1. Leukapheresis Devices
      2. Centrifugal Devices
      3. Membrane Separators
      4. Leukapheresis Disposables
    2. Global Leukapheresis Market, By Application, 2021 - 2031 (USD Million)
      1. Research Applications
      2. Therapeutic Applications
    3. Global Leukapheresis Market, By End User, 2021 - 2031 (USD Million)
      1. Blood Component Providers & Blood Centers
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Hospitals & Transfusion Centers
    4. Global Leukapheresis Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin Americe
  6. Competitive Landscape
    1. Company Profiles
      1. Asahi Kasei Medical Co. Ltd
      2. Fresenius Se & Co. KGaA
      3. Haemonetics Corporation
      4. Hemacare Corporation
      5. Key Biologics LLC
      6. Terumo BCT
      7. ALLCells LLC
      8. Stemexpress LLC
      9. Stemcell Technologies Inc
      10. Caltag Medsystems Limited
      11. Zenbio Inc
      12. Precision for Medicine Inc
      13. PPA Research Group Inc
      14. Bioivt
      15. Macopharma SA
  7. Analyst Views
  8. Future Outlook of the Market